Allel, K., Palmer, T., Abou Jaoude, G. J., Korotych, O., Yedilbayev, A., Vilc, V., . . . Skordis, J. (2025). Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova. BMJ global health, 10(11), e018099. https://doi.org/10.1136/bmjgh-2024-018099
Citace podle Chicago (17th ed.)Allel, Kasim, et al. "Cost-effectiveness of Modified Fully Oral 9-month Treatment Regimens for Rifampicin-resistant Tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova." BMJ Global Health 10, no. 11 (2025): e018099. https://doi.org/10.1136/bmjgh-2024-018099.
Citace podle MLA (9th ed.)Allel, Kasim, et al. "Cost-effectiveness of Modified Fully Oral 9-month Treatment Regimens for Rifampicin-resistant Tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova." BMJ Global Health, vol. 10, no. 11, 2025, p. e018099, https://doi.org/10.1136/bmjgh-2024-018099.